WO2000056354A3 - Methods of using agents that act on the epithelial sheet of a human eye - Google Patents
Methods of using agents that act on the epithelial sheet of a human eye Download PDFInfo
- Publication number
- WO2000056354A3 WO2000056354A3 PCT/US2000/007253 US0007253W WO0056354A3 WO 2000056354 A3 WO2000056354 A3 WO 2000056354A3 US 0007253 W US0007253 W US 0007253W WO 0056354 A3 WO0056354 A3 WO 0056354A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- epithelial sheet
- human eye
- loosening
- cornea
- agents
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/51—Lyases (4)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
Abstract
A method of delaminating the epithelial sheet of the cornea of a human eye comprising loosening the epithelial sheet with a loosening solution, the loosening solution including an agent, and separating the loosened epithelial sheet from the underlying tissue of the cornea. In the alternative, a method of delaminating the epithelial sheet from the cornea of a human eye comprising making an incision in the epithelial sheet, loosening the incised epithelial sheet using a loosening solution, the loosening solution including an agent, and separating the loosened epithelial sheet from the underlying tissue of the cornea. In addition, a method of administering a medicine through the epithelial sheet of the cornea of a human eye comprising applying a treatment solution of the medicine to the eye, the treatment solution including an agent.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12538799P | 1999-03-22 | 1999-03-22 | |
US60/125,387 | 1999-03-22 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2000056354A2 WO2000056354A2 (en) | 2000-09-28 |
WO2000056354A3 true WO2000056354A3 (en) | 2000-12-28 |
Family
ID=22419482
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2000/007253 WO2000056354A2 (en) | 1999-03-22 | 2000-03-17 | Methods of using agents that act on the epithelial sheet of a human eye |
Country Status (2)
Country | Link |
---|---|
US (1) | US6335006B1 (en) |
WO (1) | WO2000056354A2 (en) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1173790A2 (en) * | 1999-03-01 | 2002-01-23 | Boston Innovative Optics, Inc. | System and method for increasing the depth of focus of the human eye |
CA2454662A1 (en) * | 2001-07-23 | 2003-02-06 | Fos Holding S.A. | Device for separating the epithelium layer from the surface of the cornea of an eye |
US7156859B2 (en) * | 2001-07-23 | 2007-01-02 | Fos Holding S.A. | Device for separating the epithelium layer from the surface of the cornea of an eye |
US20070265650A1 (en) * | 2001-07-23 | 2007-11-15 | Ioannis Pallikaris | Device for separating the epithelial layer from the surface of the cornea of an eye |
US7153316B1 (en) * | 2001-11-09 | 2006-12-26 | Mcdonald Marguerite B | Surgical instruments and method for corneal reformation |
US7015039B1 (en) * | 2002-08-08 | 2006-03-21 | Massachusetts Eye & Ear Infirmary | Separating epithelium from stroma in LASEK surgery |
CA2498717A1 (en) * | 2002-09-13 | 2004-03-25 | Ocular Sciences, Inc. | Devices and methods for improving vision |
EP1569586A1 (en) * | 2002-12-10 | 2005-09-07 | Sightrate B.V. | Disposable separator for separating the epithelium layer from the cornea of an eye |
US20040260321A1 (en) * | 2002-12-19 | 2004-12-23 | Ming-Kok Tai | Apparatus and method for separating the epithelium layer from the cornea of an eye without corneal pre-applanation |
US20040188872A1 (en) * | 2003-03-31 | 2004-09-30 | Jani Dharmendra M. | Method for fabricating intraocular lens with peripheral sharp edge |
US7628810B2 (en) * | 2003-05-28 | 2009-12-08 | Acufocus, Inc. | Mask configured to maintain nutrient transport without producing visible diffraction patterns |
US20050046794A1 (en) * | 2003-06-17 | 2005-03-03 | Silvestrini Thomas A. | Method and apparatus for aligning a mask with the visual axis of an eye |
WO2005023159A1 (en) * | 2003-09-05 | 2005-03-17 | Sightrate B.V. | Device for separation of corneal epithelium |
MXPA03011987A (en) | 2003-12-19 | 2005-06-23 | Osio Sancho Alberto | Method for treating presbyopia by inducing changes in the corneal power and physiology. |
WO2006015490A1 (en) * | 2004-08-13 | 2006-02-16 | Ottawa Health Research Institute | Ophthalmic devices and related methods and compositions |
US7976577B2 (en) | 2005-04-14 | 2011-07-12 | Acufocus, Inc. | Corneal optic formed of degradation resistant polymer |
TW200740416A (en) * | 2006-02-08 | 2007-11-01 | Coopervision Inc | Corneal onlays and related methods |
US7883520B2 (en) * | 2006-04-10 | 2011-02-08 | Forsight Labs, Llc | Corneal epithelial pocket formation systems, components and methods |
US20100087920A1 (en) * | 2008-10-07 | 2010-04-08 | Forsight Labs, Llc | Corneal Onlay Lenses and Related Methods for Improving Vision of Presbyopic Patients |
KR101796801B1 (en) * | 2009-08-13 | 2017-11-10 | 아큐포커스, 인크. | Masked intraocular implants and lenses |
USD656526S1 (en) | 2009-11-10 | 2012-03-27 | Acufocus, Inc. | Ocular mask |
JP6046160B2 (en) | 2011-12-02 | 2016-12-14 | アキュフォーカス・インコーポレーテッド | Ophthalmic mask with selective spectral transmission |
SG11201500994SA (en) | 2012-08-10 | 2015-03-30 | Osio Corp D B A Yolia Health | Contact lens use in the treatment of an ophthalmologic condition |
US9204962B2 (en) | 2013-03-13 | 2015-12-08 | Acufocus, Inc. | In situ adjustable optical mask |
US9427922B2 (en) | 2013-03-14 | 2016-08-30 | Acufocus, Inc. | Process for manufacturing an intraocular lens with an embedded mask |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1991016070A1 (en) * | 1990-04-16 | 1991-10-31 | Bethesda Eye Institute | Enzymatic disinsertion of vitreous body |
US5626865A (en) * | 1991-10-15 | 1997-05-06 | Advanced Corneal Systems, Inc. | Enzyme-orthokeratology |
WO1998052602A1 (en) * | 1997-05-22 | 1998-11-26 | Advanced Corneal Systems, Inc. | Use of hyaluronidase in the manufacture of an ophthalmic preparation for liquefying vitreous humor in the treatment of eye disorders |
WO1999040933A1 (en) * | 1998-02-17 | 1999-08-19 | The Schepens Eye Research Institute, Inc. | Use of hyaluronidase to reduce viscoelastic related increases in intraocular pressure |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5788957A (en) | 1991-10-15 | 1998-08-04 | Advanced Corneal Systems, Inc. | Enzyme-orthokeratology |
US5866120A (en) | 1995-11-22 | 1999-02-02 | Advanced Corneal Systems, Inc. | Method for accelerating clearance of hemorrhagic blood from the vitreous humor with hyaluronidase |
-
2000
- 2000-03-17 WO PCT/US2000/007253 patent/WO2000056354A2/en active Application Filing
- 2000-03-17 US US09/528,459 patent/US6335006B1/en not_active Expired - Fee Related
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1991016070A1 (en) * | 1990-04-16 | 1991-10-31 | Bethesda Eye Institute | Enzymatic disinsertion of vitreous body |
US5626865A (en) * | 1991-10-15 | 1997-05-06 | Advanced Corneal Systems, Inc. | Enzyme-orthokeratology |
WO1998052602A1 (en) * | 1997-05-22 | 1998-11-26 | Advanced Corneal Systems, Inc. | Use of hyaluronidase in the manufacture of an ophthalmic preparation for liquefying vitreous humor in the treatment of eye disorders |
WO1999040933A1 (en) * | 1998-02-17 | 1999-08-19 | The Schepens Eye Research Institute, Inc. | Use of hyaluronidase to reduce viscoelastic related increases in intraocular pressure |
Also Published As
Publication number | Publication date |
---|---|
WO2000056354A2 (en) | 2000-09-28 |
US6335006B1 (en) | 2002-01-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2000056354A3 (en) | Methods of using agents that act on the epithelial sheet of a human eye | |
WO2006014484A3 (en) | Methods and devices for the treatment of ocular conditions | |
WO2005097219A3 (en) | Ecm-based graft material | |
WO2005034763A8 (en) | Devices, systems, and methods for suturing tissue | |
EP2087892A3 (en) | (S,S) reboxetine for treating age associated learning and mental disorders | |
HK1074577A1 (en) | The use of thymosin ß4 (Tß4), analogues, isoforms and other derivatives in the manufacture of a medicament for treating disorders of eye and the surrounding tissue | |
WO2003032815A3 (en) | Medical device for delivering patches | |
WO2001012122A3 (en) | Method and system for treating cardiac arrest using hypothermia | |
WO2004078025A3 (en) | Vascular assist device and methods | |
PL312219A1 (en) | Application of nona- and decapeptides in obtaining a therapeutic agent for fighting against aids | |
WO2005001080A3 (en) | Postpartum-derived cells for use in treatment of disease of the heart and circulatory system | |
WO2005018549A3 (en) | Methods and compositions for tissue repair | |
WO2003092584A3 (en) | Agents which regulate, inhibit, or modulate the activity and/or expression of connective tissue growth factor (ctgf) as a unique means to both lower intraocular pressure and treat glaucomatous retinopathies/optic neuropathies | |
WO2005042051A3 (en) | Method for transdermal delivery of permeant substances | |
CA2294921A1 (en) | Levobupivacaine and its use | |
WO2000018316A3 (en) | Sustained release, and comfortable ophthalmic composition and method for ocular therapy | |
AU6391000A (en) | Method of preventing the injury or death of retinal cells and treating ocular diseases | |
WO1998039293A3 (en) | 13-thia prostaglandins for use in glaucoma therapy | |
WO2002060410A3 (en) | Methods for sustained release local delivery of drugs for ablation of unwanted tissue | |
RU94039513A (en) | Method for treatment of retinal detachment complicated with subretinal schwart formation | |
WO2004010934A3 (en) | Methods for the use of neurotoxin in the treatment of urologic disorders | |
CA2414586A1 (en) | Agent for therapeutic treatment of optic nerve diseases and the like | |
WO2004038460A3 (en) | Aqueous ophthalmic spray and method for delivery | |
WO2003092669A3 (en) | Method of treating vascular endothelial growth factor mediated vascular disorders using amfenac or nepafenac | |
ATE336987T1 (en) | GEL PREPARATION CONTAINING A DISSOLVED OR SUSPENDED ACTIVE INGREDIENT, IN PARTICULAR FOR USE ON A MUCOUS SKIN AND PRODUCTION METHOD |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): JP |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): JP |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
122 | Ep: pct application non-entry in european phase |